2024年q3-2025年q1美国药品渠道格局

Q3 2024–Q1 2025 May 2025 Copyright 2025 Circana, LLC (“Circana”).All rights reserved. Circana, the Circana logo, and the names of Circanaproducts and services are trademarks of Circana. All other trademarks are the property of their respective owners. Executive Summary In this report, we follow up on trends identifiedin previous drug channel analyses and examinehow these trends compare to the broadermultioutlet and convenience channel landscape. In Q1 2025, drug channel salescontinue to lag the multioutlet marketas consumers continue to shop otherchannels to save time and money. Consumers continue to seek wellness options that aremore convenient and cost-efficient. The drug channel hasan opportunity to drive more quick trips and dollars fromthe convenience channel and expand pharmacy operations. OPPORTUNITIES KEY TRENDS Drug channel dollar sales declined 5.5% in Q1 2025. Store closures continue, but consumers are loyal to their drug storeand pharmacy. With about 40% of consumers enrolled in drug storeloyalty programs, there’s an opportunity to further engage. Drugstores should also work to increase loyalty program enrollment. The number of buyers purchasing in the drug channeldeclined less in Q1 2025 vs. Q4 2024 but is still declining asconsumers continued to shop more at other channels. Consumers are becoming more conservative about spending withconcern around inflation and the potential impact of tariffs on prices.While promo depth and breadth have remained relatively consistent,there’s been an uptick in sales lift based on promotions. Retailers canmake promos meaningful without dramatically eroding margins. Average price inflation has increased in the health and beautydepartments, which account for 66% of total dollar sales inthe drug channel. The frequency of promotions remained highthrough 2024 and into 2025. Lift saw gains toward the end of2024 and into 2025. Retail pharmacy has an opportunity to expand into a more health care-oriented space to potentially bring in more consumers. Consumersappreciate the convenience of receiving vaccines at their localpharmacy, providing an opening for more services. In the drug channel, private label sales declined vs. YA acrossmost departments, whereas in MULO+ w/ Convenience,private label has grown across all departments. Beauty department at drug declined 6% vs. YA, with thehighest sales in skincare and cosmetics. Quick trips andspecial purpose trips are the primary trip types in drug.Consumers are shopping less in the drug channel, but thedrug channel is important to consumers. There’s an opportunity to increase private label growth as consumersturn to store brands for lower prices. Products should reflect the pro-health nature of pharmacies. Drug ChannelTrends MULO+ w/ Convenience isoutperforming the drug channelDollar Sales % Change vs. YA Consumers are makingfewer drug channel trips Buyers and trips are down while $/tripis up due in large part to price inflation Drug Purchase Behaviors % Change vs. YA Consumer sentiment in the U.S. is in decline Consumers express a general sense of economic uncertainty,compounded by rising inflation and concerns about trade wars. The U.S. Index of ConsumerSentimentin April 2025 isdown from 57 in March.This was down for the fourthstraight month and the lowestsince November 2022. Health and beauty accounted for two-thirdsof drug channel volume sales Department Performance Q1 2025 Promotions consistent in bothfrequency and depth of discount; liftsaw gains as consumers seek deals Private label sales growth continues to outpacename brand in both drug and MULO+ w/ Conv Private label sales declined acrossmost departments in drug, whileMULO+ w/C grew in most categories Private Label Department Performance Q1 2025 Drug saw sales declines across alldepartments in Q1 2025, compared togrowth in MULO+ w/C in most departments Department Performance Q1 2025 Consumers are continuing toturn to the drug channel forupper respiratory remediesand vitamins Top Five Growing/Declining Categories within Health Q1 2025 +88.2%FORCE FACTOR Drug beauty sales declinedin Q1 2025 across cosmeticsand skincare Top Five Growing/Declining Categories Within Beauty Q1 2025 Deep DiveTopic Why consumers choose the drug channel Millions of families rely on the drug channel for their products. 200MLoyalty members 15MDaily customers 3rd 40% Highest shopperpenetration channel Drug channel shoppers accountfor 40% of MULO+ w/ Conv sales The drug channel is the fourth-largest retailer for non-edible products. Drug shoppersaccount for $1 for every $2.50 spent. The drug channel has the largest loyalty program. Drug store loyaltyprograms aresome ofthe most used in retail. 68%of adults agree that joining a retailer’sloyalty or rewards program encouragesthem to shop more with that retailer.ACCORDING TO MINTEL REPORTS 4out of10 drug store shoppers actively participatein a drug store’s loyalty program Consumers continue to rely